Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 20 studies | 62% ± 20% | |
lung | 19 studies | 36% ± 15% | |
kidney | 10 studies | 39% ± 15% | |
intestine | 8 studies | 36% ± 14% | |
eye | 8 studies | 40% ± 15% | |
heart | 6 studies | 32% ± 6% | |
uterus | 5 studies | 39% ± 18% | |
breast | 5 studies | 38% ± 11% | |
pancreas | 4 studies | 51% ± 22% | |
placenta | 4 studies | 52% ± 16% | |
skin | 4 studies | 25% ± 6% | |
prostate | 4 studies | 31% ± 5% | |
adipose | 4 studies | 34% ± 10% | |
esophagus | 3 studies | 37% ± 13% | |
thymus | 3 studies | 23% ± 8% | |
lymph node | 3 studies | 26% ± 10% | |
liver | 3 studies | 28% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 60948.10 | 2642 / 2642 | 100% | 885.63 | 702 / 705 |
breast | 100% | 46587.29 | 459 / 459 | 99% | 684.49 | 1108 / 1118 |
kidney | 100% | 50286.69 | 89 / 89 | 99% | 831.65 | 890 / 901 |
lung | 100% | 40698.19 | 578 / 578 | 98% | 456.13 | 1135 / 1155 |
intestine | 100% | 36935.86 | 965 / 966 | 98% | 523.64 | 518 / 527 |
thymus | 100% | 59228.57 | 653 / 653 | 98% | 704.97 | 594 / 605 |
adrenal gland | 100% | 58429.89 | 258 / 258 | 98% | 835.03 | 225 / 230 |
esophagus | 98% | 32025.23 | 1416 / 1445 | 99% | 392.05 | 181 / 183 |
stomach | 99% | 25088.12 | 354 / 359 | 98% | 456.85 | 279 / 286 |
pancreas | 97% | 16346.12 | 317 / 328 | 98% | 455.40 | 175 / 178 |
prostate | 100% | 26078.54 | 244 / 245 | 95% | 410.68 | 478 / 502 |
bladder | 100% | 40581.95 | 21 / 21 | 95% | 414.08 | 477 / 504 |
uterus | 100% | 32809.44 | 170 / 170 | 94% | 412.58 | 432 / 459 |
ovary | 100% | 34620.73 | 180 / 180 | 93% | 311.86 | 402 / 430 |
skin | 100% | 39354.21 | 1808 / 1809 | 85% | 588.09 | 400 / 472 |
liver | 90% | 12664.69 | 203 / 226 | 69% | 226.58 | 282 / 406 |
adipose | 100% | 39235.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 44307.05 | 1335 / 1335 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 117.44 | 1 / 1 |
heart | 98% | 27820.44 | 847 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 96% | 454.06 | 77 / 80 |
tonsil | 0% | 0 | 0 / 0 | 93% | 365.20 | 42 / 45 |
spleen | 92% | 15815.83 | 222 / 241 | 0% | 0 | 0 / 0 |
muscle | 40% | 4065.29 | 318 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 17% | 1994.60 | 160 / 929 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 10% | 14.59 | 3 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0032722 | Biological process | positive regulation of chemokine production |
GO_1905908 | Biological process | positive regulation of amyloid fibril formation |
GO_0010468 | Biological process | regulation of gene expression |
GO_1901224 | Biological process | positive regulation of non-canonical NF-kappaB signal transduction |
GO_0051247 | Biological process | positive regulation of protein metabolic process |
GO_0035235 | Biological process | ionotropic glutamate receptor signaling pathway |
GO_0014005 | Biological process | microglia development |
GO_0050885 | Biological process | neuromuscular process controlling balance |
GO_0050730 | Biological process | regulation of peptidyl-tyrosine phosphorylation |
GO_0051402 | Biological process | neuron apoptotic process |
GO_0045931 | Biological process | positive regulation of mitotic cell cycle |
GO_1900273 | Biological process | positive regulation of long-term synaptic potentiation |
GO_0007417 | Biological process | central nervous system development |
GO_1900272 | Biological process | negative regulation of long-term synaptic potentiation |
GO_0000086 | Biological process | G2/M transition of mitotic cell cycle |
GO_0006468 | Biological process | protein phosphorylation |
GO_0030111 | Biological process | regulation of Wnt signaling pathway |
GO_0006979 | Biological process | response to oxidative stress |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_0007626 | Biological process | locomotory behavior |
GO_0008285 | Biological process | negative regulation of cell population proliferation |
GO_0006897 | Biological process | endocytosis |
GO_0007219 | Biological process | Notch signaling pathway |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0007612 | Biological process | learning |
GO_0048143 | Biological process | astrocyte activation |
GO_0030900 | Biological process | forebrain development |
GO_0031175 | Biological process | neuron projection development |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0007155 | Biological process | cell adhesion |
GO_0008542 | Biological process | visual learning |
GO_0051124 | Biological process | synaptic assembly at neuromuscular junction |
GO_0007617 | Biological process | mating behavior |
GO_0050729 | Biological process | positive regulation of inflammatory response |
GO_2000406 | Biological process | positive regulation of T cell migration |
GO_0006878 | Biological process | intracellular copper ion homeostasis |
GO_0045821 | Biological process | positive regulation of glycolytic process |
GO_0032760 | Biological process | positive regulation of tumor necrosis factor production |
GO_0032755 | Biological process | positive regulation of interleukin-6 production |
GO_0098989 | Biological process | NMDA selective glutamate receptor signaling pathway |
GO_0010971 | Biological process | positive regulation of G2/M transition of mitotic cell cycle |
GO_0048169 | Biological process | regulation of long-term neuronal synaptic plasticity |
GO_0001774 | Biological process | microglial cell activation |
GO_0016322 | Biological process | neuron remodeling |
GO_0033138 | Biological process | positive regulation of peptidyl-serine phosphorylation |
GO_0048669 | Biological process | collateral sprouting in absence of injury |
GO_0001934 | Biological process | positive regulation of protein phosphorylation |
GO_0002265 | Biological process | astrocyte activation involved in immune response |
GO_0098815 | Biological process | modulation of excitatory postsynaptic potential |
GO_0007409 | Biological process | axonogenesis |
GO_0032731 | Biological process | positive regulation of interleukin-1 beta production |
GO_0016199 | Biological process | axon midline choice point recognition |
GO_0050808 | Biological process | synapse organization |
GO_1904646 | Biological process | cellular response to amyloid-beta |
GO_0050803 | Biological process | regulation of synapse structure or activity |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_1905606 | Biological process | regulation of presynapse assembly |
GO_0050850 | Biological process | positive regulation of calcium-mediated signaling |
GO_0007611 | Biological process | learning or memory |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0008344 | Biological process | adult locomotory behavior |
GO_0008203 | Biological process | cholesterol metabolic process |
GO_0030198 | Biological process | extracellular matrix organization |
GO_1990535 | Biological process | neuron projection maintenance |
GO_0070555 | Biological process | response to interleukin-1 |
GO_0040014 | Biological process | regulation of multicellular organism growth |
GO_0051563 | Biological process | smooth endoplasmic reticulum calcium ion homeostasis |
GO_0180011 | Biological process | cytosolic mRNA polyadenylation |
GO_0006417 | Biological process | regulation of translation |
GO_0007176 | Biological process | regulation of epidermal growth factor-activated receptor activity |
GO_0070050 | Biological process | neuron cellular homeostasis |
GO_1990000 | Biological process | amyloid fibril formation |
GO_0045665 | Biological process | negative regulation of neuron differentiation |
GO_0008088 | Biological process | axo-dendritic transport |
GO_0150003 | Biological process | regulation of spontaneous synaptic transmission |
GO_0050890 | Biological process | cognition |
GO_0010800 | Biological process | positive regulation of peptidyl-threonine phosphorylation |
GO_0016358 | Biological process | dendrite development |
GO_0001967 | Biological process | suckling behavior |
GO_0045121 | Cellular component | membrane raft |
GO_0035253 | Cellular component | ciliary rootlet |
GO_0032588 | Cellular component | trans-Golgi network membrane |
GO_0009986 | Cellular component | cell surface |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0051233 | Cellular component | spindle midzone |
GO_0008021 | Cellular component | synaptic vesicle |
GO_0005768 | Cellular component | endosome |
GO_0031904 | Cellular component | endosome lumen |
GO_0005576 | Cellular component | extracellular region |
GO_0070062 | Cellular component | extracellular exosome |
GO_0030425 | Cellular component | dendrite |
GO_0031093 | Cellular component | platelet alpha granule lumen |
GO_0030134 | Cellular component | COPII-coated ER to Golgi transport vesicle |
GO_0005798 | Cellular component | Golgi-associated vesicle |
GO_0005615 | Cellular component | extracellular space |
GO_0043235 | Cellular component | receptor complex |
GO_0005886 | Cellular component | plasma membrane |
GO_0005641 | Cellular component | nuclear envelope lumen |
GO_0016020 | Cellular component | membrane |
GO_0055037 | Cellular component | recycling endosome |
GO_0043198 | Cellular component | dendritic shaft |
GO_0005769 | Cellular component | early endosome |
GO_0005790 | Cellular component | smooth endoplasmic reticulum |
GO_0043204 | Cellular component | perikaryon |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005737 | Cellular component | cytoplasm |
GO_0005905 | Cellular component | clathrin-coated pit |
GO_0030424 | Cellular component | axon |
GO_0045177 | Cellular component | apical part of cell |
GO_0031594 | Cellular component | neuromuscular junction |
GO_0043197 | Cellular component | dendritic spine |
GO_0048471 | Cellular component | perinuclear region of cytoplasm |
GO_0005796 | Cellular component | Golgi lumen |
GO_0005911 | Cellular component | cell-cell junction |
GO_0048786 | Cellular component | presynaptic active zone |
GO_0005829 | Cellular component | cytosol |
GO_0045202 | Cellular component | synapse |
GO_0030426 | Cellular component | growth cone |
GO_0048018 | Molecular function | receptor ligand activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0046914 | Molecular function | transition metal ion binding |
GO_0120283 | Molecular function | protein serine/threonine kinase binding |
GO_0030546 | Molecular function | signaling receptor activator activity |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0005102 | Molecular function | signaling receptor binding |
GO_0019899 | Molecular function | enzyme binding |
GO_0008201 | Molecular function | heparin binding |
GO_0051425 | Molecular function | PTB domain binding |
GO_0005515 | Molecular function | protein binding |
GO_0003677 | Molecular function | DNA binding |
GO_0004867 | Molecular function | serine-type endopeptidase inhibitor activity |
Gene name | APP |
Protein name | Amyloid-beta precursor protein (ABPP) (Alzheimer disease amyloid A4 protein homolog) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) Amyloid beta protein Alternative protein APP Amyloid-beta precursor protein (APP) (ABPP) (APPI) (Alzheimer disease amyloid A4 protein homolog) (Alzheimer disease amyloid protein) (Amyloid precursor protein) (Amyloid-beta (A4) precursor protein) (Amyloid-beta A4 protein) (Cerebral vascular amyloid peptide) (CVAP) (PreA4) (Protease nexin-II) (PN-II) [Cleaved into: N-APP; Soluble APP-alpha (S-APP-alpha); Soluble APP-beta (S-APP-beta); C99 (Beta-secretase C-terminal fragment) (Beta-CTF); Amyloid-beta protein 42 (Abeta42) (Beta-APP42); Amyloid-beta protein 40 (Abeta40) (Beta-APP40); C83 (Alpha-secretase C-terminal fragment) (Alpha-CTF); P3(42); P3(40); C80; Gamma-secretase C-terminal fragment 59 (Amyloid intracellular domain 59) (AICD-59) (AID(59)) (Gamma-CTF(59)); Gamma-secretase C-terminal fragment 57 (Amyloid intracellular domain 57) (AICD-57) (AID(57)) (Gamma-CTF(57)); Gamma-secretase C-terminal fragment 50 (Amyloid intracellular domain 50) (AICD-50) (AID(50)) (Gamma-CTF(50)); C31] Amyloid beta A4 protein Amyloid-beta A4 protein |
Synonyms | AD1 A4 |
Description | FUNCTION: Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. .; FUNCTION: N-APP binds TNFRSF21 triggering caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase-6). .; FUNCTION: The gamma-CTF peptides as well as the caspase-cleaved peptides, including C31, are potent enhancers of neuronal apoptosis. . FUNCTION: Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. .; FUNCTION: N-APP binds TNFRSF21 triggering caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase-6). .; FUNCTION: The gamma-CTF peptides as well as the caspase-cleaved peptides, including C31, are potent enhancers of neuronal apoptosis. . FUNCTION: Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. Interaction between APP molecules on neighboring cells promotes synaptogenesis . Involved in cell mobility and transcription regulation through protein-protein interactions. Can promote transcription activation through binding to APBB1-KAT5 and inhibits Notch signaling through interaction with Numb. Couples to apoptosis-inducing pathways such as those mediated by G(o) and JIP. Inhibits G(o) alpha ATPase activity (By similarity). Acts as a kinesin I membrane receptor, mediating the axonal transport of beta-secretase and presenilin 1 (By similarity). By acting as a kinesin I membrane receptor, plays a role in axonal anterograde transport of cargo towards synapses in axons . Involved in copper homeostasis/oxidative stress through copper ion reduction. In vitro, copper-metallated APP induces neuronal death directly or is potentiated through Cu(2+)-mediated low-density lipoprotein oxidation. Can regulate neurite outgrowth through binding to components of the extracellular matrix such as heparin and collagen I and IV. The splice isoforms that contain the BPTI domain possess protease inhibitor activity. Induces a AGER-dependent pathway that involves activation of p38 MAPK, resulting in internalization of amyloid-beta peptide and leading to mitochondrial dysfunction in cultured cortical neurons. Provides Cu(2+) ions for GPC1 which are required for release of nitric oxide (NO) and subsequent degradation of the heparan sulfate chains on GPC1. .; FUNCTION: Amyloid-beta peptides are lipophilic metal chelators with metal-reducing activity. Bind transient metals such as copper, zinc and iron. In vitro, can reduce Cu(2+) and Fe(3+) to Cu(+) and Fe(2+), respectively. Amyloid-beta protein 42 is a more effective reductant than amyloid-beta protein 40. Amyloid-beta peptides bind to lipoproteins and apolipoproteins E and J in the CSF and to HDL particles in plasma, inhibiting metal-catalyzed oxidation of lipoproteins. APP42-beta may activate mononuclear phagocytes in the brain and elicit inflammatory responses. Promotes both tau aggregation and TPK II-mediated phosphorylation. Interaction with overexpressed HADH2 leads to oxidative stress and neurotoxicity. Also binds GPC1 in lipid rafts.; FUNCTION: Appicans elicit adhesion of neural cells to the extracellular matrix and may regulate neurite outgrowth in the brain. .; FUNCTION: The gamma-CTF peptides as well as the caspase-cleaved peptides, including C31, are potent enhancers of neuronal apoptosis.; FUNCTION: N-APP binds TNFRSF21 triggering caspase activation and degeneration of both neuronal cell bodies (via caspase-3) and axons (via caspase-6). FUNCTION: Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. . FUNCTION: Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. . FUNCTION: Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. . FUNCTION: Functions as a cell surface receptor and performs physiological functions on the surface of neurons relevant to neurite growth, neuronal adhesion and axonogenesis. . |
Accessions | Q9BYY9 H7C2L2 ENST00000357903.7 [P05067-8] ENST00000448850.5 ENST00000358918.7 [P05067-9] L7XE61 ENST00000346798.8 [P05067-1] ENST00000439274.6 ENST00000359726.7 ENST00000354192.7 [P05067-10] L7XCZ9 A0A0A0MRG2 P05067 ENST00000348990.9 [P05067-4] ENST00000415997.1 ENST00000440126.7 [P05067-11] L8EC46 A0A8F9R5D5 A0A218KGR2 E9PG40 H7C0V9 |